SAA1 and amyloidosis: Because excessive SAA levels lead to SAA deposition, which causes amyloidosis under recurrent or chronic inflammatory conditions, SAA protein is used as a blood biomarker to evaluate and monitor disease severity in patients with amyloidosis or inflammatory rheumatic disease [10].